Verve 102 is an experimental treatment designed to lower levels of low-density lipoprotein (LDL) cholesterol by targeting the PCSK9 gene in liver cells. This approach departs from traditional long-term medication regimens, as it aims to offer...
The good news of treatment of severe haemophilia A, a rare hereditary health condition, was out on 12 December 2024. Indian scientists have successfully used gene therapy to treat Haemophilia A, which is caused by a...